RGT 4.48% 35.0¢ argent biopharma limited

Ann: Voluntary Suspension Extension, page-13

  1. 1,049 Posts.
    lightbulb Created with Sketch. 241
    I believe MXC would have no choice but to withdraw the "COVID-19" claim eventually due to the aforementioned reasons pronounced by ASX:

    1. MXC has no prior experience/history engaging into COVID-19 related activities.
    2. The link between the drug delivery system "MyCells" to COVID-19 is not substantial enough. It seems that they are not inventing a new medications for the virus. Instead, they are just doing research in a system that makes medications more water soluble. To me, it is completely waste of money (in fact, they don't have much money in the bank!) and I believe money should be spent wisely on their CORE business.
    Last edited by Sparkz918: 03/04/20
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
35.0¢
Change
0.015(4.48%)
Mkt cap ! $16.94M
Open High Low Value Volume
34.5¢ 35.5¢ 33.0¢ $60.95K 174.5K

Buyers (Bids)

No. Vol. Price($)
2 11855 27.0¢
 

Sellers (Offers)

Price($) Vol. No.
37.0¢ 1338 1
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.